Observations — search entities
| Name ↑ | Type | Sources | In observations | Aliases |
|---|---|---|---|---|
| PGs | drug | 8 | 4 | polygenic risk score, polygenic score, polygenic scores, proteoglycans |
| pH | drug | 4 | 3 | acidity, post-mortem pH |
| phagocytosis | phenotype | 2 | 1 | |
| pharmacological treatment | drug | 4 | 3 | |
| Phase 1 | cohort | 3 | 2 | Phase I |
| Phase 2 | cohort | 4 | 2 | Phase 2 cohort, Phase II, hold-out set |
| phase-amplitude coupling | phenotype | 2 | 2 | PAC, alpha-gamma PAC |
| phecode | phenotype | 2 | 1 | |
| phencyclidine | drug | 5 | 4 | PCP |
| phenotype | phenotype | 70 | 38 | P, Y, disease status, four phenotypes, general factor, measure, multiple phenotypes, observed phenotype, outcome variable (Y), phenotype, phenotype of interest, phenotype values, phenotypes, phenotypic effect, trait, traits |
| phenotype 1 | phenotype | 3 | 2 | first phenotype |
| phenotype 2 | phenotype | 3 | 2 | second phenotype |
| phenotype 3 | phenotype | 3 | 1 | |
| phenotype data | phenotype | 3 | 1 | |
| phenotype of interest | phenotype | 4 | — | |
| phenotypic differences | phenotype | 2 | — | |
| phenotypic externalizing factor | phenotype | 2 | 2 | externalizing factor |
| phenotypic variance | phenotype | 7 | 3 | phenotypic variance, total phenotypic variance |
| phenotypic variation | phenotype | 3 | 2 | phenotypic variation |
| phenylalanine | drug | 2 | 1 | Phe |